Moderna Inc. revealed on Thursday that its diluted earnings per share amounted to $3.61 in the fourth quarter of fiscal 2022, representing a 68% fall compared to the previous year's corresponding trimester. Income from operations was $1.58 billion in the three months ending with December 31, 2022, marking a 71% drop from the same period last year. The company's fourth-quarter total revenue declined 29% on a yearly basis, landing at $5.08 billion.
As for the full fiscal 2022, total revenue stood at $19.28 billion, rising by 4% from 2021. Income from operations and diluted earnings per share both dropped 29% to $9.42 billion and $20.12, respectively.
Moderna's shares were 0.11% up in the premarket after the report was released.
